Trial | NCT02961361  Report issue

Official Title

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    60
Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.
Study Started
Nov 12
2016
Primary Completion
Mar 30
2017
Study Completion
May 25
2017
Last Update
Feb 15
2023

Drug ropivacaine

40 ml 0.375% ropivacaine was injected after Locating brachial plexus.

Drug ropivacaine mixed with dexmedetomidine

40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.

Group Control Experimental

40 ml 0.375% ropivacaine was injected after Locating brachial plexus.

Group Dexmedetomidine Experimental

40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.

Criteria 

Inclusion Criteria:

American Society of Anesthesiologists (ASA) physical status I or II;
Aged 18-60 years;
The elbow, forearm, wrist or hand surgery

Exclusion Criteria:

History of allergy to local anesthetics;
Coagulation dysfunction, neuromuscular disease or local infection;
The operation time is longer than the local anesthetics effective time.
No Results Posted